GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $48,000 | +2.1% | 1,245 | +6.0% | 0.02% | -5.6% |
| Q2 2021 | $47,000 | +6.8% | 1,175 | -1.3% | 0.02% | -14.3% |
| Q1 2021 | $44,000 | 0.0% | 1,190 | 0.0% | 0.02% | -4.5% |
| Q4 2020 | $44,000 | -37.1% | 1,190 | -35.9% | 0.02% | -46.3% |
| Q3 2020 | $70,000 | -23.1% | 1,857 | +74.4% | 0.04% | -35.9% |
| Q2 2020 | $91,000 | +2.2% | 1,065 | -54.5% | 0.06% | -17.9% |
| Q1 2020 | $89,000 | -26.4% | 2,341 | -9.1% | 0.08% | -17.9% |
| Q4 2019 | $121,000 | +11.0% | 2,574 | +0.9% | 0.10% | -7.8% |
| Q3 2019 | $109,000 | +11.2% | 2,550 | +4.1% | 0.10% | +19.8% |
| Q2 2019 | $98,000 | -3.0% | 2,450 | +1.3% | 0.09% | +13.2% |
| Q1 2019 | $101,000 | +16.1% | 2,418 | +5.4% | 0.08% | +16.9% |
| Q4 2018 | $87,000 | – | 2,295 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |